Wednesday, April 14, 2021
Home 2020

Yearly Archives: 2020

Hepion Pharma HEPA
Biotech News

News, As Huge As It Gets, From Hepion Pharma (HEPA) $2.10.

Editor / Curator -
Hapbee, EMulate, HAPB
Telehealth

A Medical Technology That Has The Highest Potential Over Any ...

Editor / Curator -
Internet Stock Review
Stand Down.

Is The Market Overvalued? Barron’s Round Table January 2000.

Editor / Curator -
dexamethasone, Hepion
CoronaVirus

Remember President Trump Taking Dexamethasone? Hepion’s (HEPA) CRV431 demonstrated reduced lung...

Editor / Curator -
PetVivo, Biotech Stock Review
Biotech News

And Slowly But Surely..We Have Another 10-Bagger. PetVivo (PETV).

Editor / Curator -
Hapbee
Telehealth

Jim Kwik and Kevin Harrington Join Hapbee Technologies (HAPB) Board.

Editor / Curator -
HAPBEE
All News

Hapbee (HAPB): The Netflix of Feelings

Editor / Curator -
Aphex
CoronaVirus

Aphex BioCleanse Systems (SNST) Signs European Supply and Private Label Agreement...

Editor / Curator -
All News

Mitesco (MITI) Expands ‘The Good Clinic’ to Colorado.

Editor / Curator -
Hapbee, Biotech Stock Review
Telehealth

Scott Donnell Used His Intuition to Launch Hapbee (HAPB). Video.

Editor / Curator -
123...19Page 1 of 19

Latest article

Telehealth: iRhythm Technologies, Inc. (IRTC) Opening Down $43 (32%).

All News Editor / Curator -
Let the dust settle or catch the falling knife? Down from a peak of $270, it's been a difficult...
CB Scientific, Biotech Stock Review, Telehealth

My-Cam™ and My-Cardia™ the Ultimate ‘Any-Doctor-Anywhere’ Telehealth Monitoring Application.

Telehealth Editor / Curator -
New and Updated Report on CB Scientific (CBSC) $1.05. Revolutionary Any-Doctor-Any Where, at Home Heart Rate Monitor, can...
Internet Stock Review

Two of Our $5.00 Watch List Stocks Double, in Like Just Five Months!

AI Artificial Intelligence Editor / Curator -
Added to the Watch List in November, OMNIQ (OMQS) and Galaxy Digital (GLXY) Shine like a Pretty Penny, with OMNIQ Doubling...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: roland@institutionalanalyst.com
© Managed by Revelers.IO Media Group Inc.